94-11023. National Institutes of Health National Cancer Institute; Meetings of the National Cancer Advisory Board and Its Subcommittees  

  • [Federal Register Volume 59, Number 88 (Monday, May 9, 1994)]
    [Unknown Section]
    [Page 0]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 94-11023]
    
    
    [[Page Unknown]]
    
    [Federal Register: May 9, 1994]
    
    
    -----------------------------------------------------------------------
    
    
    FEDERAL TRADE COMMISSION
     
    
    National Institutes of Health National Cancer Institute; Meetings 
    of the National Cancer Advisory Board and Its Subcommittees
    
        Pursuant to Public Law 92-463, notice is hereby given of the 
    meeting of the National Cancer Advisory Board, National Cancer 
    Institute, and its Subcommittees on May 31 and June 1, 1994. The full 
    Board will meet in Conference Room 10, 6th Floor, Building 31C, 
    National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 
    20892. Meetings of the Subcommittees of the Board will be held at the 
    times and places listed below. Except as noted below, the meetings of 
    the Board and its Subcommittees will be open to the public to discuss 
    issues relating to committee business as indicated in the notice. 
    Attendance by the public will be limited to space available.
        A portion of the Board meeting will be closed to the public in 
    accordance with the provisions set forth in sections 552b(c)(4) and 
    552b(c)(6), title 5, U.S.C. and section 10(d) of Public Law 92-463, for 
    the review, discussion and evaluation of individual grant applications. 
    These applications and the discussions could reveal confidential trade 
    secrets or commercial property such as patentable material, and 
    personal information concerning individuals associated with the 
    applications, the disclosure of which would constitute a clearly 
    unwarranted invasion of personal privacy.
        The Committee Management Office, National Cancer Institute, 
    National Institutes of Health, Executive Plaza North, room 630, 9000 
    Rockville Pike, Bethesda, Maryland 20892 (301/496-5708), will provide a 
    summary of the meeting and roster of the Board members, upon request.
        Individuals who plan to attend and need special assistance, such as 
    sign language interpretation or other reasonable accommodations, should 
    contact Ms. Carole Frank, Committee Management Specialist, at 301/496-
    5708 in advance of the meeting.
    
    Name of Committee: National Cancer Advisory Board.
    Executive Secretary: Dr. Marvin R. Kalt, Executive Plaza North, room 
    600A Bethesda, MD 20892; (301) 496-5147.
    Dates of Meeting: May 31-June 1, 1994.
    Place of Meeting: Building 31C, Conference Room 10.
    Open: May 31--8 a.m. to approximately 12 noon.
    Agenda: Report on activities of the President's Cancer Panel; the 
    Director's Report on the National Cancer Institute; and Scientific 
    Presentations.
    Closed: May 31--3 p.m. to recess.
    Agenda: For review and discussion of individual grant applications.
    Open: June 1--8 a.m. to adjournment.
    Agenda: Policy and Scientific Presentations, subcommittee Reports; and 
    New Business.
    
    Name of Committee: Subcommittee on Planning and Budget.
    Executive Secretary: Ms. Cherie Nichols, Building 31, room 11A19 
    Bethesda, MD 20892; (301) 496-5515.
    Date of Meeting: May 31, 1994.
    Place of Meeting: Building 31C, Conference Room 8.
    Open: 2 p.m. to 3 p.m.
    Agenda: To discuss the NCI budget and various planning issues.
    
    Name of Committee: Clinical Investigations Task Force.
    Executive Secretary: Dr. Bruce Chabner, Building 31, room 3A52 
    Bethesda, MD 20892; (301) 496-4291.
    Date of Meeting: May 31, 1994.
    Place of Meeting: Building 31C, Conference Room 8.
    Open: Immediately following the recess of the NCAB's closed session.
    Agenda: To discuss clinical investigational issues.
    
    Name of Committee: Subcommittee for Special Priorities.
    Executive Secretary: Ms. Iris Schneider, Building 31, room 11A48 
    Bethesda, MD 20892; (301) 496-5534.
    Date of Meeting: May 31, 1994.
    Place of Meeting: Building 31C, Conference Room 9.
    Open: 2 p.m. to 3 p.m.
    Agenda: To discuss issues related to special priorities.
    
    Name of Committee: Subcommittee on Information and Cancer Control.
    Executive Secretary: Mr. Paul Van Nevel, Building 31, room 10A31, 
    Bethesda, MD 20892; (301) 496-6631.
    Date of Meeting: May 31, 1994.
    Place of Meeting: Building 31C, Conference Room 9.
    Open: 1 p.m. to 2 p.m.
    Agenda: To discuss cancer control issues.
    
    Name of Committee: Subcommittee on Cancer Centers.
    Executive Secretary: Dr. Brian Kimes, Executive Plaza North, room 300 
    Bethesda, MD 20892; (301) 496-8537.
    Date of Meeting: May 31, 1994.
    Place of Meeting: Building 31C, Conference 8.
    Open: 1 p.m. to 2 p.m.
    Agenda: To discuss the cancer centers.
    
    Name of Committee: Subcommittee on Environmental Carcinogenesis.
    Executive Secretary: Dr. Richard Adamson, Building 31, room 11A03, 
    Bethesda, MD 20892; (301) 496-6618.
    Date of Meeting: May 31, 1994.
    Place of Meeting: Building 31C, Conference 9.
    Open: Immediately following the recess of the NCAB's closed session.
    Agenda: To discuss environmental carcinogenesis.
    
    Catalog of Federal Domestic Assistance Program Numbers: (93.393, 
    Cancer Cause and Prevention Research; 93.394, Cancer Detection and 
    Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, 
    Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, 
    Cancer Research Manpower; 93.399, Cancer Control)
    
        Dated: May 3, 1994.
    Susan K. Feldman,
    Committee Management Officer, NIH.
    [FR Doc. 94-11023 Filed 5-6-94; 8:45 am]
    BILLING CODE 4140-01-M
    
    
    

Document Information

Published:
05/09/1994
Department:
Federal Trade Commission
Entry Type:
Uncategorized Document
Document Number:
94-11023
Pages:
0-0 (1 pages)
Docket Numbers:
Federal Register: May 9, 1994